Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
25%
Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Other(2)

Detailed Status

unknown2
Completed2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (33.3%)
N/A2 (66.7%)

Trials by Status

unknown250%
completed250%

Recent Activity

0 active trials
Showing 4 of 4
unknownphase_2

Clinical Evaluation of a New Form of Cancer Therapy (Atavistic Chemotherapy) Based on the Principles of Atavistic Metamorphosis (2011)

NCT02366884
completednot_applicable

Furosemide Stress Test Guiding Initiation of Renal Replacement Therapy

NCT02730117
completed

Comparison of IgA Levels in the Bronchoalveolar Lavage Fluid of Patients With and Without Antibiotic Therapy

NCT02912520
unknownnot_applicable

Glue Sealing for Patients With Low-Output ECFs

NCT01672593

Clinical Trials (4)

Showing 4 of 4 trials
NCT02366884Phase 2

Clinical Evaluation of a New Form of Cancer Therapy (Atavistic Chemotherapy) Based on the Principles of Atavistic Metamorphosis (2011)

Unknown
NCT02730117Not Applicable

Furosemide Stress Test Guiding Initiation of Renal Replacement Therapy

Completed
NCT02912520

Comparison of IgA Levels in the Bronchoalveolar Lavage Fluid of Patients With and Without Antibiotic Therapy

Completed
NCT01672593Not Applicable

Glue Sealing for Patients With Low-Output ECFs

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4